Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP603129.RANqn2IozhVakMzx_EtfeE1YBVNkBnf-wy_IV6DdDVOXA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP603129.RANqn2IozhVakMzx_EtfeE1YBVNkBnf-wy_IV6DdDVOXA130_assertion type Assertion NP603129.RANqn2IozhVakMzx_EtfeE1YBVNkBnf-wy_IV6DdDVOXA130_head.
- NP603129.RANqn2IozhVakMzx_EtfeE1YBVNkBnf-wy_IV6DdDVOXA130_assertion description "[HCN1 and HCN2 expression were measured using in situ hybridization and immunocytochemistry in hippocampi from three groups: TLE with hippocampal sclerosis (HS; n = 17), epileptic hippocampi without HS, or non-HS (NHS; n = 10), and autopsy material (n = 10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP603129.RANqn2IozhVakMzx_EtfeE1YBVNkBnf-wy_IV6DdDVOXA130_provenance.
- NP603129.RANqn2IozhVakMzx_EtfeE1YBVNkBnf-wy_IV6DdDVOXA130_assertion evidence source_evidence_literature NP603129.RANqn2IozhVakMzx_EtfeE1YBVNkBnf-wy_IV6DdDVOXA130_provenance.
- NP603129.RANqn2IozhVakMzx_EtfeE1YBVNkBnf-wy_IV6DdDVOXA130_assertion SIO_000772 12890777 NP603129.RANqn2IozhVakMzx_EtfeE1YBVNkBnf-wy_IV6DdDVOXA130_provenance.
- NP603129.RANqn2IozhVakMzx_EtfeE1YBVNkBnf-wy_IV6DdDVOXA130_assertion wasDerivedFrom befree-20140225 NP603129.RANqn2IozhVakMzx_EtfeE1YBVNkBnf-wy_IV6DdDVOXA130_provenance.
- NP603129.RANqn2IozhVakMzx_EtfeE1YBVNkBnf-wy_IV6DdDVOXA130_assertion wasGeneratedBy ECO_0000203 NP603129.RANqn2IozhVakMzx_EtfeE1YBVNkBnf-wy_IV6DdDVOXA130_provenance.